Cargando…
Cost or revenue: is diabetes prevention doomed due to misalignment of incentives?
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032896/ https://www.ncbi.nlm.nih.gov/pubmed/32148736 http://dx.doi.org/10.1136/fmch-2019-000274 |
| _version_ | 1783499562819780608 |
|---|---|
| author | Mainous 3rd, Arch G Yadav, Sandhya Xie, Zhigang Huo, Jinhai |
| author_facet | Mainous 3rd, Arch G Yadav, Sandhya Xie, Zhigang Huo, Jinhai |
| author_sort | Mainous 3rd, Arch G |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7032896 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70328962020-03-06 Cost or revenue: is diabetes prevention doomed due to misalignment of incentives? Mainous 3rd, Arch G Yadav, Sandhya Xie, Zhigang Huo, Jinhai Fam Med Community Health Commentary BMJ Publishing Group 2020-01-19 /pmc/articles/PMC7032896/ /pubmed/32148736 http://dx.doi.org/10.1136/fmch-2019-000274 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Commentary Mainous 3rd, Arch G Yadav, Sandhya Xie, Zhigang Huo, Jinhai Cost or revenue: is diabetes prevention doomed due to misalignment of incentives? |
| title | Cost or revenue: is diabetes prevention doomed due to misalignment of incentives? |
| title_full | Cost or revenue: is diabetes prevention doomed due to misalignment of incentives? |
| title_fullStr | Cost or revenue: is diabetes prevention doomed due to misalignment of incentives? |
| title_full_unstemmed | Cost or revenue: is diabetes prevention doomed due to misalignment of incentives? |
| title_short | Cost or revenue: is diabetes prevention doomed due to misalignment of incentives? |
| title_sort | cost or revenue: is diabetes prevention doomed due to misalignment of incentives? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032896/ https://www.ncbi.nlm.nih.gov/pubmed/32148736 http://dx.doi.org/10.1136/fmch-2019-000274 |
| work_keys_str_mv | AT mainous3rdarchg costorrevenueisdiabetespreventiondoomedduetomisalignmentofincentives AT yadavsandhya costorrevenueisdiabetespreventiondoomedduetomisalignmentofincentives AT xiezhigang costorrevenueisdiabetespreventiondoomedduetomisalignmentofincentives AT huojinhai costorrevenueisdiabetespreventiondoomedduetomisalignmentofincentives |